Compare Bank Pembangunan Daerah Jawa Timur Tbk (BJTM) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank Pembangunan Daerah Jawa Timur Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Pembangunan Daerah Jawa Timur Tbk trades at Rp515 (market cap 7.58T, 7.89M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Bank Pembangunan Daerah Jawa Timur Tbk is far larger — about 46× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Pembangunan Daerah Jawa Timur Tbk is more actively traded (7.89M versus 214.9K). Which is the better fit depends on your goals.
| BJTM | OBAT | |
|---|---|---|
Market Cap | 7.58T | 164.65B |
Volume | 7.89M | 214.9K |
Lot | 78.94K | 2.15K |
Turnover | 4.01B | 51.97M |
Average Price | 507.6 | 241.85 |
Value | 4.01B | 51.97M |
Indicative Equilibrium Price | 515 | 240 |
Indicative Equilibrium Volume | 280 | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank Pembangunan Daerah Jawa Timur Tbk
PT Bank Pembangunan Daerah Jawa Timur Tbk (the Bank) was established under the name of PT Bank Pembangunan Daerah Djawa Timur dated August 17, 1961. The Bank started its commercial operations in accordance with the Decision Letter of the Minister of Finance of the Republic of Indonesia No. BUM 9-4-5 on August 15, 1961. The Sharia Operating Unit started its commercial operations on August 21, 2007 in accordance with the approval letter from Bank Indonesia No. 9/75/DS/Sb dated April 4, 2007 for the establishment of the Bank's Sharia Unit.
Read more on BJTM →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
